Work

In silico Prediction Followed By in Vitro validation Identifies the Survivin Inhibitor YM155 As a Potent Secondary Drug Against Pi-Resistant Myeloma

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-131923

Authors: Harish Kumar, Ujjal Kumar Mukherjee, Li Chen, Amit Kumar Mitra

Institutions: Auburn University, University of Illinois Urbana-Champaign, University of Alabama at Birmingham, UAB Medicine

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2983980526

Cites:

Cited by:

Related to: 10